Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported Q1 CY2025 results , but sales fell by 5.6% year on year to ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other best pharma stocks to invest in now amid the ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

(Reuters) -Bristol Myers Squibb said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

The announcement of new investment was first made by CEO Christopher Boerner in an opinion piece published in Stat News on Monday, and was later confirmed to Reuters by a company spokesperson.